BILAXIN Ophta 6 mg / ml gtt opht 6 mg 5 ml
7680686570023
CH-68657
S01GX13
11.06.2.
Active substances:
1 / 2
google
Details
- Product number
- 6865701
- CPT
- -
- Packaging group
- 5
- Unit
- ml
- Composition
- bilastinum 6 mg, hydroxypropylbetadexum, methylcellulosum, natrii hyaluronas, glycerolum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
BILAXIN Ophta 6 mg / ml, Augentropfen, Lösung
Augentropfen
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
bilastinum
|
6.0 MG | Substance | Wirkstoff (Principe actif) |
|
hydroxypropylbetadexum
|
- | Substance | HNIDK |
|
methylcellulosum
|
- | Substance | HNIDK |
|
natrii hyaluronas
|
- | Substance | HNIDK |
|
glycerolum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
A. Menarini GmbH
8050 Zürich
Authorization information
- Swissmedic authorization number
- 68657
- Drug name
- BILAXIN Ophta, Augentropfen, Lösung
- Galenic form
- AUL
- ATC Code
- S01GX13
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 09/12/2022
- Authorization expiration date
- 08/12/2027
- IT number
- 11.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BILAXIN Ophta 6 mg / ml gtt opht 6 mg 5 ml
- Description (DE)
- BILAXIN Ophta 6 mg / ml Trp Opht 6 mg 5 ml
- Market launch
- 31/12/2028
- Narcotic (BTM)
- No